| SC 13G/A | 2024-02-14 | ARMISTICE CAPITAL, LLC | SUPERNUS PHARMACEUTICALS, INC. | 4,650,000 | 8.5% | EDGAR |
| SC 13G | 2024-02-14 | MACQUARIE GROUP LTD | SUPERNUS PHARMACEUTICALS, INC. | 2,737,721 | 5.0% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | SUPERNUS PHARMACEUTICALS, INC. | 6,214,731 | 11.4% | EDGAR |
| SC 13G/A | 2024-01-19 | BlackRock Inc. | SUPERNUS PHARMACEUTICALS, INC. | 10,381,318 | 19.0% | EDGAR |
| SC 13G/A | 2023-02-14 | ARMISTICE CAPITAL, LLC | SUPERNUS PHARMACEUTICALS, INC. | 4,356,000 | 8.1% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | SUPERNUS PHARMACEUTICALS, INC. | 5,789,960 | 10.7% | EDGAR |
| SC 13G/A | 2023-01-23 | BlackRock Inc. | SUPERNUS PHARMACEUTICALS, INC. | 9,604,073 | 17.8% | EDGAR |
| SC 13G/A | 2022-02-15 | ARMISTICE CAPITAL, LLC | SUPERNUS PHARMACEUTICALS, INC. | 4,136,000 | 7.8% | EDGAR |
| SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | SUPERNUS PHARMACEUTICALS, INC. | 5,513,149 | 10.4% | EDGAR |
| SC 13G/A | 2022-01-27 | BlackRock Inc. | SUPERNUS PHARMACEUTICALS, INC. | 8,451,022 | 15.9% | EDGAR |
| SC 13G/A | 2022-01-26 | BlackRock Inc. | SUPERNUS PHARMACEUTICALS, INC. | 8,451,022 | 15.9% | EDGAR |
| SC 13G/A | 2021-02-16 | ARMISTICE CAPITAL, LLC | SUPERNUS PHARMACEUTICALS, INC. | 3,120,000 | 5.9% | EDGAR |
| SC 13G/A | 2021-02-10 | VANGUARD GROUP INC | SUPERNUS PHARMACEUTICALS, INC. | 5,298,078 | 10.1% | EDGAR |
| SC 13G | 2021-01-25 | BlackRock Inc. | SUPERNUS PHARMACEUTICALS, INC. | 8,912,801 | 16.9% | EDGAR |
| SC 13G | 2020-03-12 | ARMISTICE CAPITAL, LLC | SUPERNUS PHARMACEUTICALS, INC. | 2,888,000 | 5.5% | EDGAR |
| SC 13G/A | 2020-02-12 | VANGUARD GROUP INC | SUPERNUS PHARMACEUTICALS, INC. | 5,305,889 | 10.1% | EDGAR |
| SC 13G/A | 2020-02-10 | BlackRock Inc. | SUPERNUS PHARMACEUTICALS, INC. | 8,734,832 | 16.6% | EDGAR |
| SC 13D | 2019-04-25 | Khattar Jack A. | SUPERNUS PHARMACEUTICALS INC | 2,747,265 | 5.1% | EDGAR |
| SC 13G/A | 2019-02-11 | BlackRock Inc. | SUPERNUS PHARMACEUTICALS INC | 8,075,659 | 15.5% | EDGAR |
| SC 13G/A | 2019-01-10 | VANGUARD GROUP INC | SUPERNUS PHARMACEUTICALS INC | 5,238,062 | 10.0% | EDGAR |